immune-related aes in patients with breast cancer treated with io
Published 10 months ago • 63 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
3:32
multisystem immune-related aes with immunotherapy in nsclc
-
2:45
correlation between cutaneous immune-related adverse events and os with immune checkpoint inhibitors
-
3:03
immune-related adverse events in breast cancer patients taking icis
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
2:24
the remaining challenges surrounding the use of immunotherapy to treat patients with rectal cancer
-
0:31
assessing immune-enhancing nutrition in patients with cancer undergoing surgery
-
1:42
managing immune-related adverse events in adjuvant immunotherapy
-
3:05
immune adverse events of checkpoint inhibitors
-
3:54
neurological adverse events associated with immune checkpoint inhibitors
-
3:30
side effects of immune checkpoint inhibitors
-
1:35
sitc clinical practice guidelines on immune checkpoint inhibitor-related adverse events
-
0:51
monitor toxicities when treating breast cancer with immunotherapy
-
42:03
harnessing the immune system to fight cancer
-
14:42
managing toxicities associated with immune-checkpoint inhibitors
-
52:27
immunotherapy/checkpoint inhibitor, targeted immunotherapy drugs 5/2/18
-
45:09
breast cancer: the latest target for immunotherapy, with leisha emens
-
24:29
dr anna olsson brown navigating side effects of melanoma treatment
-
1:12
dr. emens on immune-related adverse events in ovarian cancer
-
8:43
fianlimab and cemiplimab in patients with advanced melanoma